SPECT bei zerebrovaskulären Erkrankungen

  • L. Pávics

Zusammenfassung

Die ersten Untersuchungen mit der Emissionscomputertomographie (ECT) sind bei zerebrovaskulären Erkrankungen durchgeführt worden [1]. Die Entwicklung hat die nuklearmedizinischen Methoden in den letzten Jahren dramatisch verändert. Es sind verschiedene für die pathophysiologischen Prozesse immer spezifischere Radiopharmaka und für deren Abbildung hochentwickelte tomographische Geräte auf den Markt gekommen. Die Positronenemissionstomographie (PET) ermöglicht es, verschiedene hämodynamische und metabolische Parameter und deren Veränderungen im Verlauf von zerebrovaskulären Erkrankungen in vivo zu erfassen [2, 3]. Während die PET noch immer überwiegend in der Forschung eingesetzt wird, hat die Single-Photon-Emissions- Computertomographie (SPECT) ihren Platz in der breiteren klinischen Anwendung frühzeitig gefunden und weiterhin behauptet.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Lassen NA, Ingvar DH (1972) Radioisotopic assessment of regional cerebral blood flow. Karger, Basel and Univ Park Press, Baltimore Progress Nuclear Medicine 1, pp 376–409Google Scholar
  2. 2.
    Powers WJ, Raichle ME (1985) Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke 16:361–376PubMedCrossRefGoogle Scholar
  3. 3.
    Heiss W-D, Herholz K (1994) Assessment of pathophysiology of stroke by positron emission tomography. Eur J Nucl Med 21:455–465PubMedCrossRefGoogle Scholar
  4. 4.
    Bailey DL, Zito F, Gilardi M-C, Savi AR, Fazio F, Jones T (1994) Performance of a state of the art neuro-SPECT scanner and a dedicated neuro-PET scanner. Eur J Nucl Med 21:381–387PubMedCrossRefGoogle Scholar
  5. 5.
    Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K (1992) A quantitative approach to technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 19:195–200PubMedCrossRefGoogle Scholar
  6. 6.
    Pupi A, De Cristofaro MTR, Bacciottini L, Antoniucci D, Formiconi AR, Mascalchi M, Meldolesi U (1991) An analysis of the arterial input curve for technetium-99m-HMPAO: quantification of rCBF using single-photon emission tomography. J Nucl Med 32:1501–1506PubMedGoogle Scholar
  7. 7.
    Pupi A, Castagnoli A, De Cristofaro MTR, Bacciottini L, Petti AR (1994) Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: measurement of arterial input and brain retention. Eur J Nucl Med 21:124–130PubMedCrossRefGoogle Scholar
  8. 8.
    Andersen AR, Friberg H, Knudsen GM et al. (1988) Extraction of (99mTc)-d, l-HM-PAO across the blood brain barrier. J Cereb Blood Flow Metab 8:S44-S51PubMedCrossRefGoogle Scholar
  9. 9.
    Knudsen GM, Andersen AR, Somnier FE, Videbaeck Ch, Hasselbalch S, Paulson OB (1994) Brain extraction and distribution of 99mTc-Bicisate in humans and in rats. J Cereb Blood Flow Metab 14:S12-S18PubMedCrossRefGoogle Scholar
  10. 10.
    Knapp WH, Kummer R, Kuebler AW (1986) Imaging of cerebral blood flow to volume distribution using SPECT. J Nucl Med 27:465–470PubMedGoogle Scholar
  11. 11.
    Buell U, Braun H, Ferbert A, Stirner H, Weiller C, Ringelstein EB (1988) Combined SPECT imaging of regional cerebral blood flow (99mTc-hexamethyl-propyleneamine Oxime, HMPAO) and blood volume (99mTc-RBC) to assess regional cerebral perfusion reserve in patients with cerebrovascular disease. Nucl Med 27:51–56Google Scholar
  12. 12.
    Toyama H, Takeshita G, Takeuchi A et al. (1990) Cerebral haemodynamics in patients with chronic obstructive carotid disease by rCBF, rCBV and rCBV/rCBF ratio using SPECT. J Nucl Med 31: 55–60PubMedGoogle Scholar
  13. 13.
    Pävics L, Kuncz Ä, Ambrus E, Döczi T, Bodosi M, Csernay L (1992) The role of combined rCBF- rCBV SPECT studies in the evaluation of intracranial arteriovenous malformations (AVM-s). In: Schmidt HAE, Höfer R (eds) Nuclear Medicine Schattauer, Stuttgart, pp 438–441Google Scholar
  14. 14.
    Wallis JW, Miller TR (1991) Three-dimensional display in nuclear medicine and radiology. J Nucl Med 32:534–546PubMedGoogle Scholar
  15. 15.
    Kung HF, Ohmomo Y, Kung M-P (1990) Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography. Semin Nucl Med 20:290–302PubMedCrossRefGoogle Scholar
  16. 16.
    Winchell HS, Baldwin RM, Lin TH (1980) Development of 1–123 labeled amines for brain studies: localization of 1–123 iodophenylalkyl amines in rat brain. J Nucl Med 21:940–947PubMedGoogle Scholar
  17. 17.
    Neirinckx RD, Canning LR, Piper IM et al. (1987) Technetium-99m d,I,-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28:191-202PubMedGoogle Scholar
  18. 18.
    Walovitch RC, Hill TC, Garrity ST et al. (1989) Characterization of technetium-99m, L, L-ECD for brain perfusion imaging, part 1: pharmacology of technetium-99m ECD in nonhuman primates. J Nucl Med 30:1892–1901PubMedGoogle Scholar
  19. 19.
    Hayashida K, Nishimura T, Imakita S, Uehara T (1989) Filling out phenomen with technetium-99m HM-PAO brain SPECT at the site of mild cerebral ischemia. J Nucl Med 30:591–598PubMedGoogle Scholar
  20. 20.
    Vallabhajosula S, Zimmerman RE, Picard M et al. (1989) Technetium-99m ECD: A new brain imaging agent: In vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 30:599–604PubMedGoogle Scholar
  21. 21.
    Croft BY (1990) Instrumentation and computers for brain single photon emission computed tomography. Semin Nucl Med 20:281–289PubMedCrossRefGoogle Scholar
  22. 22.
    Ring HA, George M, Costa DC, Ell PJ (1991) The use of cerebral activation procedures with single photon emission tomography. Eur J Nucl Med 18:133–141PubMedCrossRefGoogle Scholar
  23. 23.
    Yudd AP, Vafn Heertum RL, Masdeu JC (1991) Interventions and functional brain imaging. Semin Nucl Med 21:153–158PubMedCrossRefGoogle Scholar
  24. 24.
    Hayashida K, Hirose Y, Kaminaga T et al. (1993) Detection of postural cerebral hypoperfusion with technetium-99m-HMPAO brain SPECT in patients with cerebrovascular disease. J Nucl Med 34:1931–1935PubMedGoogle Scholar
  25. 25.
    Nakagawara J, Nakamura J, Takeda R et al. (1994) Assessment of postischemic reperfusion and DIAMOX activation test in stroke using 99mTc-ECD SPECT. J Cereb Blood Flow Metab 14:S49-S57PubMedCrossRefGoogle Scholar
  26. 26.
    Overbeck B, Rosanowski F, Grünwald F, Bockisch A, von Itter C, Biersack HJ, Herberhold C (1991) HMPAO SPECT unter Karotiskompression (Matas-Test) in der Diagnostik vor zervikalen Tumoreingriffen mit möglicher Karotisbeteiligung. Laryngho-Rhino-Otol 70:422–425CrossRefGoogle Scholar
  27. 27.
    Maethews D, Walker BS, Purdy PD et al. (1993) Brain blood flow SPECT in temporary balloon occlusion of carotid and intracerebral arteries. J Nucl Med 34:1239–1243Google Scholar
  28. 28.
    Askienazy S, Lebtahi R, Meder J-F (1993) SPECT HMPAO and balloon test occlusion: Interest in predicting tolerance prior to permanent cerebral artery occlusion. (Editorial) J Nucl Med 34:1243–1245PubMedGoogle Scholar
  29. 29.
    Palestro CJ, Sen C, Muzinic M, Afriyie M, Goldsmith SJ (1993) Assessing collateral perfusion with technetium-99m-HMPAO SPECT during temporary internal carotid occlusion. J Nucl Med 34:1235–1238PubMedGoogle Scholar
  30. 30.
    Rieker O, Ries F, Grünwald F et al. (1993) HMPAO- SPECT in the presurgical evaluation of cerebral blood flow during balloon test occlusion with and without acetazolamide. Eur J Nucl Med 20:830 (Abstract)Google Scholar
  31. 31.
    Holman LB, Devous MD (1992) Functional brain SPECT: The emergence of a powerful clinical method. J Nucl Med 33:1888–1903PubMedGoogle Scholar
  32. 32.
    Pávics L, Barzó P, Maté E, Ambrus E, Katona É, Morvay Z, Csernay L (1992) Rest and stress (acetazolamide) rCBF-SPECT and transcranial Doppler sonography studies in cerebrovascular disorders. Eur J Nucl Med 19: 594 (Abstract)Google Scholar
  33. 33.
    Hellman RS, Tikofsky RS (1990) An overview of the contribution of regional cerebral blood flow studies isn cerebrovascular disease: Is there a role for single photon emission computed tomography? Semin Nucl Med 20:303–324PubMedCrossRefGoogle Scholar
  34. 34.
    Burt RW, Witt RM, Cikrit DF, Reddy RV (1992) Carotid artery disease: evaluation with Acetazolamide-enhanced 99mTc-HMPAO SPECT. Radiology 182:461–466PubMedGoogle Scholar
  35. 35.
    Podreka I, Brücke T, Wenger S et al. (1993) Einsatz der SPECT in der Neurologischen Diagnostik. Der Nuklearmediziner 16:99–110Google Scholar
  36. 36.
    The EC-IC Bypass Study Group (1985) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. N Engl J Med 313:1191–1200CrossRefGoogle Scholar
  37. 37.
    Samson Y, Baron JC, Bousser MG, Rey A, Derlon JM, David P, Comoy J (1985) Effects of extra- intracranial bypass on cerebral blood flow and oxygen metabolism in humans. Stroke 16:609–616PubMedCrossRefGoogle Scholar
  38. 38.
    Russel D, Dybevold S, Kjartansson O, Nyberg-Hnasen R, Rootwelt K, Wibweg J (1990) Cerebral vasoreactivity and blood flow before and 3 months after carotid endarterectomy. Stroke 21:1029–1032CrossRefGoogle Scholar
  39. 39.
    Ramsay SC, Yeates MG, Hille N, Yeates P, Eberl P, Reid C, Fernandes V (1991) Use of technetium- HMPAO to demonstrate changes in cerebral blood flow reserve following carotid endarterectomy. J Nucl Med 32:1382–1386PubMedGoogle Scholar
  40. 40.
    Yeh SH, Liu RS, Hu HH et al. (1986) Brain SPECT imaging with 99mTc-hexamethylpropyleneamine oxime in the early detection of cerebral infarction: comparison with transmission computed tomography. Nucl Med Commun 7:873–878PubMedCrossRefGoogle Scholar
  41. 41.
    Podreka I, Suess E, Goldenberg G (1987) Initial experience with technetium-99m HMPAO brain SPECT. J Nucl Med 28:1657–1666PubMedGoogle Scholar
  42. 42.
    De Roo M, Mortelmans L, Devos P et al. (1989) Clinical experience with 99mTc-HMPAO high resolution SPECT of the brain in patients with cerebrovascular accidents. Eur J Nucl Med 15:9–15PubMedCrossRefGoogle Scholar
  43. 43.
    Shimosegawa E, Hatazawa J, Inugami A et al. (1994) Cerebral infarction within six hours of onset: Prediction of completed infarction with technetium-99m-HMPAO SPECT. J Nucl Med 35:1097–1103PubMedGoogle Scholar
  44. 44.
    Feeney DM, Baron J-C (1986) Diaschisis. Stroke 17:817–831PubMedCrossRefGoogle Scholar
  45. 45.
    Von-Monakow C [1914, article translated by G. Harris] (1969) In: Pribram KH (ed) Brain and behavior I: Mood states and mind. Penguin, Baltimore, pp 27–36Google Scholar
  46. 46.
    Biersack HJ, Hartmann A, Friedrich G, Fröscher M, Reichmann K, Reske SN, Knopp R (1984) Zur Ursache der gekreuzten zerebellaren Diaschisis bei zerebrovaskulärer Erkrankung. Nuklearmedizin 23:227–230PubMedGoogle Scholar
  47. 47.
    Mountz JM, Modell JG, Foster NL et al. (1990) Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. J Nucl Med 31:61–66PubMedGoogle Scholar
  48. 48.
    Moretti JL, Defer G, Cinotti L et al. (1990) “Luxury perfusion” with 99mTc-HM-PAO and (123I)-IMP SPECT imaging during the subacute phase of stroke. Eur J Nucl Med 16:17–22PubMedCrossRefGoogle Scholar
  49. 49.
    Sperling B, Lassen NA (1993) Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT. Stroke 24:193–194PubMedCrossRefGoogle Scholar
  50. 50.
    Brass LM, Walowitch RC, Joseph JL et al. (1994) The role of single photon emission computed tomography brain imaging with 99mTc-Bicisate in the localization and definition of mechanism of ischemic stroke. J Cereb Blood Flow Metab 14:S91-S98PubMedGoogle Scholar
  51. 51.
    Lassen NA, Sperling B (1994) 99mTc-bicisate reliably images CBF in chronic brain disease but fails to show reflow hyperemia in subacute stroke: Report of multicenter trial of 105 cases comparing 133Xe and 99mTc-bicisate (ECD, Neurolite) measured by SPECT on same day. J Cereb Blood Flow Metab 14:S44-S48PubMedGoogle Scholar
  52. 52.
    Tsuchida T, Nishizawa S, Yonekura Y et al. (1993) SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: Comparison with other cerebral perfusion tracers and PET. J Nucl Med 35:27–31Google Scholar
  53. 53.
    Pävics L, Döczi T, Bodosi M, Csernay L (1990) 99mTc-HMPAO brain SPECT studies in patients with occlusive disease of the internal carotid artery. Nucl Med 2:85–89Google Scholar
  54. 54.
    Maini CL, Castellano G, Benech F, Podio V, Cornaglia, Fontanella M (1990) 99mTc-HMPAO brain SPECT in subarachnoid haemorrhage. Nucl Med Commun 11:491–502CrossRefGoogle Scholar
  55. 55.
    Soucy JP, McNamara D, Mohr G, Lamourux F, Danais S (1990) Evaluation of vasospasm secondary to subarachnoid hemorrhage with technetium 99m-hexamethyl-propyleneamine oxime (HMPAO) tomoscintigraphy. J Nucl Med 31:972–977PubMedGoogle Scholar
  56. 56.
    Lewis DH, Eskridge JM, Newell DW et al. (1992) Brain SPECT and the effect of cerebral angioplasty in delayed ischemia due to vasospasm. J Nucl Med 33:1789–1796PubMedGoogle Scholar
  57. 57.
    Pävics L, Barzö P, Borda L, Ambrus E, Almasi L, Vörös E, Buga K, Döczi T, Bodosi M, Csernay L (1993) Comparative regional cerebral blood flow (rCBF) SPECT, angiography (DSA) and transcranial Doppler sonography (TCD) studies in the evaluation of vasospasm in subarachnoid hemorrhage (SAH). Eur J Nucl Med 20:821 (Abstract)Google Scholar
  58. 58.
    Menzel C, Reinhold U, Grünwald F et al. (1994) Cerebral blood flow in Sneddon syndrome. J Nucl Med 35:461–464PubMedGoogle Scholar
  59. 59.
    Inoue Y, Momose T, Machida K, Honda N, Tsutsumi K (1993) Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in Moyamoya disease. J Nucl Med 34:1984–1986PubMedGoogle Scholar
  60. 60.
    Buell U, Costa DC, Kirsch G, Moretti JL, Van Royen EA, Schober O (1990) The investigation of dementia with single photon emission tomography. Nucl Med Commun 11:823–841PubMedGoogle Scholar
  61. 61.
    Bonte FJ, Horn J, Tintner R, Weiner MF (1990) Single photon tomography in Alzheimer’s disease and the dementias. Semin Nucl Med 20:342–352PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • L. Pávics

There are no affiliations available

Personalised recommendations